word m and a made with wood building blocks, stock image

Maksim Labkouski

Intercept Pharmaceuticals (NASDAQ:ICPT) has been downgraded to hold by Canaccord Genuity in the wake of news that the biotech group has agreed to be acquired by Alfasigma for $19 per share in cash.

Canaccord said in a note that it

Image and article originally from seekingalpha.com. Read the original article here.